CD 130 Pill: brown , capsule/oblong, 19mm
The pill with imprint CD 130 (Brown, Capsule/Oblong1) has been identified as Ranitidine Hydrochloride 300 mg and is used for GERD, Erosive Esophagitis, Gastric Ulcer Maintenance Treatment, Duodenal Ulcer Prophylaxis, and Cutaneous Mastocytosis. It belongs to the drug class H2 antagonists and is not a controlled substance.
Images for CD 130
Ranitidine Hydrochloride
- Imprint
- CD 130
- Strength
- 300 mg
- Color
- Brown
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy’s Laboratories Inc.
- Inactive Ingredients
-
magnesium stearate,
microcrystalline cellulose,
sodium starch glycolate type A potato,
ferrosoferric oxide,
ferric oxide red,
ferric oxide yellow,
titanium dioxide,
gelatin
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 42291-0736 (Discontinued) | AvKare, Inc. |
| 55111-0130 (Discontinued) | Dr. Reddy's Laboratories, Inc. |
Related images for "CD 130"
More about ranitidine
- Check interactions
- Compare alternatives
- Reviews (163)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: H2 antagonists
- Breastfeeding
Patient resources
Other brands
Professional resources
- Ranitidine prescribing information
- Ranitidine Capsule (FDA)
- Ranitidine Injection (FDA)
- Ranitidine Syrup (FDA)
- Ranitidine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.